Clonidine Blocks Acquisition But not Expression of Conditioned Opiate Withdrawal in Rats
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Previous studies in rodents have reported that clonidine, an alpha 2-adrenergic receptor agonist, attenuated conditioned aversions to naloxone-precipitated opiate withdrawal when administered prior to each withdrawal conditioning episode. The current study was designed to determine whether clonidine could modify the expression of previously established conditioned place aversions and conditioned suppression of operant responding. Dose- and time-dependent effects of clonidine on activity and suppression of operant responding for food identified appropriate treatment parameters for subsequent studies in which rats rendered dependent on opiates through implantation of morphine pellets were tested for: (1) conditioned place aversion; and (2) conditioned suppression of operant responding for food (fixed ratio-15 schedule), in a paradigm wherein rats received four pairings of naloxone with a distinct tone and odor stimulus. Clonidine dose-dependently blocked the acquisition of both conditioned behaviors when administered prior to naloxone on each conditioning trial, but was ineffective in blocking the expression of these conditioned withdrawal signs when administered prior to the test session.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415
Clonidine blocks acute opiate-withdrawal symptoms
Gold, M., Redmond, D. E., & Kleber, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92823-4 · Cited by 710 · cited 2×
“For example, clonidine, a noradrenergic alpha 2 agonist, has been found in both clinical (Charney et al. 1981; Cuthill et al. 1990; Dawe and Gray 1995; Gold et al. 1978; Janiri et al. 1994; Jasinski et al. 1985; Kasvikis et al. 1990) and preclinical animal studies (Coupar 1992; Katz 1986; Kelsey et al.”
Dynamics of Drug Dependence: Implications of a Conditioning Theory for Research and Treatment
Wikler, A. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750350005001 · Cited by 648 · cited 2×
“…withdrawal symptomatology and conditioned reinforcement processes in maintaining addiction and promoting relapse after periods of abstention (Childress et al. 1994; Jasinski et al. 1985; O’Brien et al. 1976, 1993; Ramsay and Woods 1997; Schulteis and Koob 1996; Schulteis et al. 1997a; Wikler 1973).”
Stinus, L., Le Moal, M., & Koob, G. F. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90106-e · Cited by 317 · cited 2×
“Distinctive visual and tactile cues distinguished the three compartments (for details, see Stinus et al. 1990).”
Schulteis, G., Markou, A., Gold, L. H., Stinus, L., & Koob, G. F. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24024-1 · Cited by 285 · cited 5×
“…with conditioned place aversion, a behavioral paradigm that serves as a sensitive animal model of affective opiate withdrawal (Hand et al. 1988; Schulteis et al. 1994), suggested that clonidine administered prior to each conditioning trial could block the acquisition of a conditioned aversion…”
InfluentialSelf-citationCan induced moods trigger drug-related responses in opiate abuse patients?
Childress, A. R., Ehrman, R., McLellan, A. T., MacRae, J., Natale, M., & O'Brien, C. P. (1994) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(94)90060-4 · Cited by 171 · cited 2×
“…acquire motivational significance in maintaining compulsive use and in precipitating relapse after periods of abstention (Baldwin and Koob 1993; Childress et al. 1994; O’Brien From the Department of Neuropharmacology (GS, VBR, GFK), The Scripps Research Institute, La Jolla; Department of…”
Clonidine in Morphine Withdrawal: Differential Effects on Signs and Symptoms
Jasinski, D. R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790340041006 · Cited by 163 · cited 4×
“For example, clonidine, a noradrenergic alpha 2 agonist, has been found in both clinical (Charney et al. 1981; Cuthill et al. 1990; Dawe and Gray 1995; Gold et al. 1978; Janiri et al. 1994; Jasinski et al. 1985; Kasvikis et al. 1990) and preclinical animal studies (Coupar 1992; Katz 1986; Kelsey et al.”
InfluentialBiological consequences of drug administration: Implications for acute and chronic tolerance
Ramsay, D. S., & Woods, S. C. (1997) · Psychological Review · doi:10.1037/0033-295x.104.1.170 · Cited by 155 · cited 5×
“…withdrawal symptomatology and conditioned reinforcement processes in maintaining addiction and promoting relapse after periods of abstention (Childress et al. 1994; Jasinski et al. 1985; O’Brien et al. 1976, 1993; Ramsay and Woods 1997; Schulteis and Koob 1996; Schulteis et al. 1997a; Wikler 1973).”
InfluentialCharney, D. S. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780360089010 · Cited by 145 · cited 2×
“For example, clonidine, a noradrenergic alpha 2 agonist, has been found in both clinical (Charney et al. 1981; Cuthill et al. 1990; Dawe and Gray 1995; Gold et al. 1978; Janiri et al. 1994; Jasinski et al. 1985; Kasvikis et al. 1990) and preclinical animal studies (Coupar 1992; Katz 1986; Kelsey et al.”
Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal
Koob, G. F., Wall, T. L., & Bloom, F. E. (1989) · Psychopharmacology · doi:10.1007/bf00441954 · Cited by 142
Cited by
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056
Brain stress systems in the amygdala and addiction
Koob, G. F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.038 · Cited by 388
“Precipitated withdrawal in opioid dependence also produces anxietylike effects (Schulteis et al., 1998;Harris and Aston-Jones, 1993).”
BackgroundDrug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“Systemic CRF receptor antagonist and functional noradrenergic receptor antagonist administration blocked naloxone-precipitated conditioned place aversion in opioid-dependent rats (Schulteis et al., 1998; Stinus et al., 2005).”
Background
Metadata
- Authors
- Schulteis, G.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Schulteis, G
- Venue
- Neuropsychopharmacology
- Published
- 1998-11
- Volume
- 19
- Issue
- 5
- Pages
- 406-416
- ISSN
- 0893-133X (ISSN-L)
- OpenAlex
- W1999527583
- Cited by
- 37
- References
- 39
- Citations by year
- 2020: 1 · 2018: 1 · 2014: 3 · 2013: 1 · 2012: 1
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondation pour la Recherche Médicale
- Centre National de la Recherche Scientifique
- Université de Bordeaux
- National Institute on Drug Abuse (DA04043, DA-10475, R01DA004043)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- clonidine, naloxone-precipitated withdrawal, conditioned place aversion, alpha-2 adrenergic agonists, opioid use disorder, dose-dependent effects
- MeSH terms
- Adrenergic alpha-Agonists, Analgesics, Opioid, Animals, Clonidine, Conditioning, Operant, Male, Morphine, Naloxone, Narcotics, Substance Withdrawal Syndrome, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clonidine Blocks Acquisition But not Expression of Conditioned Opiate Withdrawal in Rats. https://app.cochat.ai/papers/10.1016/s0893-133x(98)00036-0
- The paper
- Schulteis, G. (1998). Clonidine Blocks Acquisition But not Expression of Conditioned Opiate Withdrawal in Rats. Neuropsychopharmacology. https://doi.org/10.1016/s0893-133x(98)00036-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.